Global Cardiac Assist Devices Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com Report Description Report Description Heart Failure (HF) is a potentially life-threatening condition that weakens the heart muscle, reduces its ability to pump enough blood throughout the body. Even without a heart transplant, patients' lives can be extended and improved with the use of small, implantable devices called Cardiac Assist Devices. Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. The devices are typically employed in patients suffering from EndStage Congestive Heart Failure, where the chances of survival through oral medications alone become minimal. The scarcity of donor organs has led to the development of these devices. Globally, there are around 23 million cases of HF and around 5.8 million people in United States have HF. About half of the people who develop heart failure die within 5 years of diagnosis. Browse Full Report@ http://www.futuremarketinsights.com/reports/cardiac-assistdevices-market Cardiac Assist Devices Market: Drivers & Restraints The Cardiac Assist Devices market is driven by aging population, increasing prevalence of HF, high adaptation rates of these devices, and new technology innovations. Increasing rates of cardiovascular diseases and aging population has boosted the cardiac assist devices market globally. Report Description Report Description The shortage of donor hearts for transplantation is also leading to an increase in adoption of cardiac assist devices in patients with end-stage heart failure. Cardiac assist devices are also being used as a Bridge-To-Transplantation (BTT), Bridge-ToRecovery (BTR) or Destination Therapy (DT), depending on the requirement of the patient and the severity of the disease. Technological advancements that make the devices more efficient and minimally invasive are expected to further drive the demand for cardiac assist devices in the future. Presence of alternative treatment like heart transplantation, pacemaker and etc. and the few risk which are associated with the device implantation, such as development of blood clots, respiratory failure and device failure and other surgical complications such as bleeding, kidney failure, stroke and infection. Such complication are acting as a barrier in the adoption of such treatment and devices. Cardiac Assist Devices Market: Segmentation The global market of cardiac assist devices is segmented into following types: • Ventricular Assist Devices (VAD) • Intra-Aortic Balloon Pumps (IABP) • Total Artificial Heart (TAH) Further, Ventricular Assist Device (VAD) are segmented into the following types based on the defect and placement of the device. Report Description Report Description • Left Ventricular Assist Device (LVAD) • Right Ventricular Assist Device (RVAD) • Bi-Ventricular Assist Device (Bi-VAD) • External Ventricular Assist Device (VAD) Cardiac Assist Devices Market: Overview With rapid technological advancement and wide acceptance of cardiac surgery procedures among patients with heart problem, the global cardiac assist devices market is expected to exhibit a double-digit growth in the forecast period (2015-2025). Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-467 With FDA approving SynCardia System’s Total Artificial Heart to conduct clinical studies on destination therapy, more and more end stage heart failure patient will be benefit from this nature of therapy and the market is expected to expand significantly in the forecast period. Cardiac Assist Devices Market: Region-wise Outlook Depending on geographic regions, global cardiac assist devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Report Description Report Description North America is the leading markets for cardiac assist devices with highest prevalent cases with heart failure, technological development, high patient awareness and reimbursement coverage for CAD implantation procedures. Europe is the second largest market followed by Asia Pacific and Japan. Cardiac Assist Devices Market: Key Players Some of the key market players in global cardiac assist devices market are Thoratec Corporation, MAQUET GmbH & Co., Teleflex Incorporated, Heart Ware International, Berlin Heart GmbH, ABIOMED and SynCardia Systems, Inc. About Us Report Description Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705
Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. The devices are typically employed in patients suffering from End-Stage Congestive Heart Failure, where the chances of survival through oral medications alone become minimal. The scarcity of donor organs has led to the development of these devices.
© Copyright 2024 Paperzz
